Skip to main content
AAN.com

Abstract

Objective: To evaluate the sensitivity of transcranial magnetic stimulation (TMS) to identify upper motor neuron involvement in patients with motor neuron disease.
Background: Diagnosis of ALS depends on upper and lower motor neuron involvement. Lower motor neuron involvement may be documented with electromyography, whereas definite evidence of upper motor neuron involvement may be elusive. A sensitive, noninvasive test of upper motor neuron function would be useful.
Methods: TMS and clinical assessment in 121 patients with motor neuron disease.
Results: TMS revealed evidence of upper motor neuron dysfunction in 84 of 121 (69%) patients, including 30 of 40 (75%) patients with only probable upper motor neuron signs and unsuspected upper motor neuron involvement in 6 of 22 (27%) patients who had purely lower motor neuron syndromes clinically. In selected cases, upper motor neuron involvement identified with TMS was verified in postmortem examination. Increased motor evoked potential threshold was the abnormality observed most frequently and was only weakly related to peripheral compound muscle action potential amplitude. In a subset of 12 patients reexamined after 11 ± 6 months, TMS showed progression of abnormalities, including progressive inexcitability of central motor pathways and loss of the normal inhibitory cortical stimulation silent period.
Conclusions: TMS provides a sensitive means for the assessment and monitoring of excitatory and inhibitory upper motor neuron function in motor neuron disease.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Lambert EH. Electromyography in amyotrophic lateral sclerosis. In: Norris FH, Kurland LT, eds. Motor neuron diseases: research on amyotrophic lateral sclerosis and related disorders. New York:Grune & Stratton, 1969:135–153.
2.
Triggs WJ, Edgar MA. A 61-year-old man with increasing weakness and atrophy of all extremities. Case records of the Massachusetts General Hospital. N Engl J Med 1995;333:1406–1412.
3.
Elliott JL. A clearer view of upper motor neuron dysfunction in amyotrophic lateral sclerosis. Arch Neurol 1998;55:910–912.
4.
Thompson PD, Day BL, Rothwell JC, et al. The interpretation of electromyographic responses to electrical stimulation of the motor cortex in diseases of the upper motor neurone. J Neurol Sci 1987;80:91–110.
5.
Ingram DA, Swash M. Central motor conduction is abnormal in motor neuron disease. J Neurol Neurosurg Psychiatry 1987;50:159–166.
6.
Hugon J, Lubeau M, Tabaraud F, Chazot F, Vallat JM, Dumas M. Central motor conduction in motor neuron disease. Ann Neurol 1987;22:544–546.
7.
Schriefer TN, Hess CW, Mills KR, Murray NMF. Central motor conduction studies in motor neurone disease using magnetic brain stimulation. Electroencephalogr Clin Neurophysiol 1989;74:431–437.
8.
Eisen A, Shytbel W, Murphy K, Hoirch M. Cortical magnetic stimulation in amyotrophic lateral sclerosis. Muscle Nerve 1990;13:146–151.
9.
Berardelli A, Inghilleri M, Cruccu G, Mercuri B, Manfredi M. Electrical and magnetic transcranial stimulation in patients with corticospinal damage due to stroke or motor neurone disease. Electroencephalogr Clin Neurophysiol 1991;81:389–396.
10.
Caramia MD, Cicinelli P, Paradiso C, et al. “Excitability” changes of muscular responses to magnetic brain stimulation in patients with central motor disorders. Electroencephalogr Clin Neurophysiol 1991;81:243–250.
11.
Uozumi T, Tsuji S, Murai Y. Motor potentials evoked by magnetic stimulation of the motor cortex in normal subjects and patients with motor disorders. Electroencephalogr Clin Neurophysiol 1991;81:251–256.
12.
Triggs WJ, Macdonell RAL, Cros D, Chiappa KH, Shahani BT, Day BJ. Motor inhibition and excitation are independent effects of magnetic cortical stimulation. Ann Neurol 1992;32:345–351.
13.
Eisen A, Pant B, Stewart H. Cortical excitability in amyotrophic lateral sclerosis : a clue to pathogenesis. Can J Neurol Sci 1993;20:11–16.
14.
Younger DS, Rowland LP, Latov N, et al. Motor neuron disease and amyotrophic lateral sclerosis : relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990;40:595–599.
15.
Kent Braun JA, Walker CH, Weiner MW, Miller RG. Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve 1998;21:762–768.
16.
Day BL, Rothwell JC, Thompson PD, et al. Delay in the execution of voluntary movement by electrical or magnetic brain stimulation in intact man. Brain 1989;112:649–663.
17.
Prout AJ, Eisen AA. The cortical silent period and amyotrophic lateral sclerosis. Muscle Nerve 1994;17:217–223.
18.
Claus D. Central motor conduction : method and normal results. Muscle Nerve 1990;13:1125–1132.
19.
Claus D, Brunholzl C, Kerling FP, Henschel S. Transcranial magnetic stimulation as a diagnostic and prognostic test in amyotrophic lateral sclerosis. J Neurol Sci 1995;129 (suppl):30–34.
20.
Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994;44:1933–1938.
21.
Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997;48:878–881.
22.
Block W, Karitzky J, Traber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease. Arch Neurol 1998;55:931–936.
23.
Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998;50:1800–1805.
24.
Ross MA, Miller RG, Berchert L, et al. Toward earlier diagnosis of amyotrophic lateral sclerosis : revised criteria. Neurology 1998;50:768–772.
25.
Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124 (suppl):96–107.
26.
Hess CW, Mills KR, Murray NMF. Responses in small hand muscles from magnetic stimulation of the human brain. J Physiol 1987;388:397–419.
27.
Mills KR. Motor neuron disease. Studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation. Brain 1995;118:971–982.
28.
Mills KR, Nithi KA. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis. Muscle Nerve 1997;20:1137–1141.
29.
Eisen A, Entezari Taher M, Stewart H. Cortical projections to spinal motoneurons : changes with aging and amyotrophic lateral sclerosis. Neurology 1996;46:1396–1404.
30.
Enterzari Taher M, Eisen A, Stewart H, Nakajima M. Abnormalities of cortical inhibitory neurons in amyotrophic lateral sclerosis. Muscle Nerve 1997;20:65–71.
31.
Kohara N, Kaji R, Kojima Y, et al. Magnetic stimulation in ALS : a single motor unit study. Electroencephalogr Clin Neurophysiol 1996;46:327–336.
32.
Yokota T, Yoshino A, Inaba A, Saito Y. Double cortical stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996;61:596–600.
33.
Ziemann U, Winter M, Reimers CD, Reimers K, Tergau F, Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis : evidence from paired transcranial magnetic stimulation. Neurology 1997;49:1292–1298.
34.
Eisen A, Stewart H, Schulzer M, Cameron D. Anti-glutamate therapy in amyotrophic lateral sclerosis : a trial using lamotrigine. Can J Neurol Sci 1993;20:297–301.

Information & Authors

Information

Published In

Neurology®
Volume 53Number 3August 1, 1999
Pages: 605
PubMed: 10449127

Publication History

Received: December 7, 1998
Accepted: March 9, 1999
Published online: August 1, 1999
Published in print: August 1, 1999

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

W.J. Triggs, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.
D. Menkes, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.
J. Onorato, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.
R.S.- H. Yan, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.
M.S. Young, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.
K. Newell, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.
H.W. Sander, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.
O. Soto, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.
K.H. Chiappa, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.
D. Cros, MD
From the Department of Neurology and the Human Motor Physiology Laboratory (Drs. Triggs and Young)the University of Florida College of Medicine, Gainesville, FL; and the Department of Neurology and EMG Laboratory (Drs. Menkes, Onorato, Tan, Sander, Soto, Chiappa, and Cros) and Pathology (Dr. Newell), Massachusetts General Hospital, Boston, MA.

Notes

Address correspondence and reprint requests to Dr. Didier Cros, EMG Laboratory, Massachusetts General Hospital, Boston, MA 02114.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Physiological Biomarkers of Upper Motor Neuron Dysfunction in ALS, Brain Sciences, 14, 8, (760), (2024).https://doi.org/10.3390/brainsci14080760
    Crossref
  2. Cortical inexcitability in ALS: correlating a clinical phenotype, Journal of Neurology, Neurosurgery & Psychiatry, (jnnp-2024-333928), (2024).https://doi.org/10.1136/jnnp-2024-333928
    Crossref
  3. Diagnosis and differential diagnosis of MND/ALS: IFCN handbook chapter, Clinical Neurophysiology Practice, 9, (27-38), (2024).https://doi.org/10.1016/j.cnp.2023.12.003
    Crossref
  4. Novel approaches to assessing upper motor neuron dysfunction in motor neuron disease/amyotrophic lateral sclerosis: IFCN handbook chapter, Clinical Neurophysiology, 163, (68-89), (2024).https://doi.org/10.1016/j.clinph.2024.04.010
    Crossref
  5. Contribution of neurophysiology to the diagnosis and monitoring of ALS, Motor Neurone Disease, (87-118), (2024).https://doi.org/10.1016/bs.irn.2024.04.001
    Crossref
  6. Sex-specific reference values for total, central, and peripheral latency of motor evoked potentials from a large cohort, Frontiers in Human Neuroscience, 17, (2023).https://doi.org/10.3389/fnhum.2023.1152204
    Crossref
  7. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee, Clinical Neurophysiology, 150, (131-175), (2023).https://doi.org/10.1016/j.clinph.2023.03.010
    Crossref
  8. Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis, Neural Regeneration Research, 17, 1, (65), (2022).https://doi.org/10.4103/1673-5374.314289
    Crossref
  9. Cortical Hyperexcitability in the Driver’s Seat in ALS, Clinical and Translational Neuroscience, 6, 1, (5), (2022).https://doi.org/10.3390/ctn6010005
    Crossref
  10. Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials, Journal of Neuromuscular Diseases, 9, 1, (25-37), (2022).https://doi.org/10.3233/JND-210754
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share